Found 300 matching trials
A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers PHASE1 To test the ability of GSK256073 to block niacin-induced flushing when GSK2...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis NA This study looks at whether niacin improves reverse cholesterol transport (...
Show More Location
University of Pennsylvania
Learn More & Join Trial
Assessing the Effects of Increased Mitochondrial Function Exercise Training on Muscle Performance NA As people grow older skeletal muscle gradually becomes smaller and weaker, ...
Show More Location
NIHR Exeter Clinical Research Facility
Learn More & Join Trial
Combined Radiotherapy and Sorafenib in Patients With Hepatoma N/A This study aims to test the efficacy of combined radiotherapy and sorafenib...
Show More Learn More & Join Trial
Nicotinic Acid Composition of HDL and Arterial Endothelium Function in Premature Coronary Heart Disease and High HDL PHASE4 Patients with premature ischemic heart disease (PIHD) and elevated levels o...
Show More Location
Unitat Funcional de Risc Vascular. Servei Medicina Interna. Hospital Universitari de Bellvitge.
Learn More & Join Trial
Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM) PHASE3 To evaluate efficacy and safety of sorafenib versus placebo in the adjuvant...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Oral Nicotinamide as an Adjunctive Therapy in Patients With Sepsis PHASE4 Sepsis is a severe, life-threatening condition caused by an abnormal host r...
Show More Location
El Demardash Hospital
Learn More & Join Trial
Open-label Study to Assess Increasing Levels of NAD+(Nicotinamide Adenine Dinucleotide) NA The purpose of this study is to assess an effective single oral supplement ...
Show More Location
Life Extension Clinical Research, Inc.
Learn More & Join Trial
Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067) PHASE3 This is a 12-Week clinical trial in patients with Primary hypercholesterole...
Show More Location
Multiple Locations
Learn More & Join Trial
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy PHASE2 This study will treat participants with newly diagnosed, low, intermediate ...
Show More Status
Active Not Recruiting
Location
University of Florida Proton Therapy Institute
Learn More & Join Trial